Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acquired Immunodeficiency Syndrome | 78 | 2012 | 2197 | 2.170 |
Why?
|
HIV Envelope Protein gp120 | 17 | 2012 | 914 | 1.310 |
Why?
|
Methamphetamine | 2 | 2020 | 165 | 1.150 |
Why?
|
HIV-1 | 26 | 2020 | 6858 | 1.130 |
Why?
|
Sarcoma, Kaposi | 26 | 2005 | 374 | 1.120 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 7 | 2014 | 119 | 1.080 |
Why?
|
Megakaryocytes | 18 | 1999 | 566 | 1.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 4 | 2015 | 1650 | 1.070 |
Why?
|
Mitogen-Activated Protein Kinases | 9 | 2007 | 1242 | 0.940 |
Why?
|
Zidovudine | 20 | 1994 | 624 | 0.930 |
Why?
|
Protein-Tyrosine Kinases | 17 | 2001 | 2425 | 0.920 |
Why?
|
Sulfones | 4 | 2012 | 447 | 0.920 |
Why?
|
Receptors, Cell Surface | 6 | 2017 | 2802 | 0.890 |
Why?
|
CD4-Positive T-Lymphocytes | 7 | 2020 | 4366 | 0.840 |
Why?
|
Task Performance and Analysis | 2 | 2016 | 763 | 0.780 |
Why?
|
Efficiency, Organizational | 2 | 2016 | 695 | 0.750 |
Why?
|
Nerve Tissue Proteins | 4 | 2015 | 4408 | 0.720 |
Why?
|
Dendritic Cells | 3 | 2017 | 2722 | 0.680 |
Why?
|
Microfilament Proteins | 2 | 2017 | 1130 | 0.660 |
Why?
|
HIV | 22 | 2012 | 1579 | 0.660 |
Why?
|
Lymphoma, Mantle-Cell | 3 | 2012 | 237 | 0.660 |
Why?
|
Chemokines, CXC | 7 | 2006 | 416 | 0.660 |
Why?
|
Virus Replication | 12 | 2020 | 2427 | 0.650 |
Why?
|
Endothelium, Vascular | 14 | 2010 | 4433 | 0.640 |
Why?
|
Receptors, sigma | 1 | 2019 | 45 | 0.630 |
Why?
|
Focal Adhesion Kinase 2 | 15 | 2012 | 87 | 0.620 |
Why?
|
Herpesvirus 8, Human | 3 | 2007 | 255 | 0.610 |
Why?
|
Salaries and Fringe Benefits | 1 | 2020 | 256 | 0.590 |
Why?
|
Personal Autonomy | 1 | 2020 | 304 | 0.580 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 14 | 1994 | 888 | 0.580 |
Why?
|
HIV Infections | 23 | 2020 | 17337 | 0.560 |
Why?
|
AIDS-Related Complex | 16 | 1992 | 107 | 0.550 |
Why?
|
Professional Competence | 1 | 2020 | 431 | 0.550 |
Why?
|
Receptors, Growth Factor | 5 | 2001 | 326 | 0.530 |
Why?
|
Gene Products, tat | 3 | 2001 | 111 | 0.520 |
Why?
|
Colony-Stimulating Factors | 7 | 1991 | 218 | 0.520 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 2 | 2015 | 161 | 0.520 |
Why?
|
Public Health | 2 | 2024 | 2669 | 0.510 |
Why?
|
Hematopoietic Stem Cells | 12 | 2010 | 3394 | 0.510 |
Why?
|
Hepatocytes | 5 | 2012 | 1231 | 0.500 |
Why?
|
Styrenes | 2 | 2012 | 23 | 0.500 |
Why?
|
Viral Envelope Proteins | 12 | 2005 | 640 | 0.490 |
Why?
|
Cell Adhesion Molecules | 4 | 2017 | 1602 | 0.490 |
Why?
|
Apoptosis | 12 | 2012 | 9476 | 0.490 |
Why?
|
Cell Movement | 12 | 2014 | 5200 | 0.490 |
Why?
|
Phosphorylation | 24 | 2019 | 8311 | 0.480 |
Why?
|
Hepacivirus | 6 | 2012 | 1330 | 0.460 |
Why?
|
Receptors, CXCR4 | 6 | 2017 | 727 | 0.460 |
Why?
|
Paxillin | 10 | 2012 | 86 | 0.460 |
Why?
|
Receptors, Chemokine | 4 | 2007 | 652 | 0.460 |
Why?
|
Interleukin-1beta | 1 | 2020 | 998 | 0.450 |
Why?
|
Cyclin D1 | 3 | 2012 | 451 | 0.450 |
Why?
|
Lectins, C-Type | 2 | 2017 | 584 | 0.450 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2014 | 127 | 0.450 |
Why?
|
Receptor Protein-Tyrosine Kinases | 7 | 2001 | 1626 | 0.440 |
Why?
|
Medicine | 2 | 2012 | 942 | 0.430 |
Why?
|
Enzyme Activation | 13 | 2015 | 3591 | 0.430 |
Why?
|
Research | 4 | 2012 | 1977 | 0.430 |
Why?
|
Hematopoiesis | 13 | 2010 | 2049 | 0.420 |
Why?
|
Cytoskeleton | 4 | 2015 | 1170 | 0.420 |
Why?
|
Endocannabinoids | 2 | 2010 | 111 | 0.420 |
Why?
|
Lymphangiogenesis | 1 | 2014 | 171 | 0.410 |
Why?
|
Religion and Medicine | 2 | 2004 | 161 | 0.410 |
Why?
|
Physician-Patient Relations | 5 | 2010 | 3239 | 0.410 |
Why?
|
Recombinant Proteins | 33 | 2004 | 6520 | 0.400 |
Why?
|
Receptors, CCR5 | 3 | 2017 | 486 | 0.400 |
Why?
|
Endothelium, Lymphatic | 1 | 2012 | 63 | 0.390 |
Why?
|
Delivery of Health Care | 3 | 2016 | 5332 | 0.390 |
Why?
|
Receptors, Immunologic | 4 | 2015 | 1409 | 0.390 |
Why?
|
Didanosine | 4 | 1993 | 151 | 0.390 |
Why?
|
Cocaine | 1 | 2017 | 958 | 0.380 |
Why?
|
Burnout, Professional | 1 | 2020 | 703 | 0.380 |
Why?
|
Deltaretrovirus | 12 | 1986 | 162 | 0.370 |
Why?
|
Central Nervous System Stimulants | 1 | 2020 | 1177 | 0.370 |
Why?
|
Vocabulary | 1 | 2011 | 166 | 0.370 |
Why?
|
Chemotaxis, Leukocyte | 4 | 2006 | 661 | 0.370 |
Why?
|
Interleukin-8 | 3 | 2005 | 696 | 0.360 |
Why?
|
Arachidonic Acids | 2 | 2010 | 294 | 0.360 |
Why?
|
Bisphenol A-Glycidyl Methacrylate | 1 | 2010 | 15 | 0.360 |
Why?
|
Receptor, Cannabinoid, CB2 | 5 | 2010 | 48 | 0.360 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 5 | 1999 | 438 | 0.350 |
Why?
|
Hematopoietic Cell Growth Factors | 5 | 1994 | 98 | 0.350 |
Why?
|
Bone Marrow | 13 | 1997 | 2909 | 0.350 |
Why?
|
Motivation | 1 | 2020 | 2003 | 0.350 |
Why?
|
Signal Transduction | 23 | 2012 | 23416 | 0.340 |
Why?
|
Cytoskeletal Proteins | 10 | 2001 | 1336 | 0.340 |
Why?
|
Tumor Cells, Cultured | 19 | 2012 | 6126 | 0.340 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 2003 | 457 | 0.340 |
Why?
|
Monocytes | 9 | 2001 | 2565 | 0.330 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2012 | 693 | 0.330 |
Why?
|
Glycine | 2 | 2012 | 661 | 0.330 |
Why?
|
Hazardous Substances | 1 | 2010 | 153 | 0.320 |
Why?
|
Ethics, Research | 2 | 2008 | 176 | 0.320 |
Why?
|
History, 20th Century | 7 | 2011 | 2764 | 0.310 |
Why?
|
Humanism | 1 | 2009 | 86 | 0.310 |
Why?
|
History, 21st Century | 6 | 2011 | 1565 | 0.310 |
Why?
|
Humans | 200 | 2024 | 760617 | 0.310 |
Why?
|
Electronic Health Records | 2 | 2016 | 4803 | 0.310 |
Why?
|
Cell Line | 26 | 2014 | 15576 | 0.310 |
Why?
|
Economics, Medical | 1 | 2009 | 112 | 0.310 |
Why?
|
Chemotaxis | 3 | 2007 | 598 | 0.300 |
Why?
|
src-Family Kinases | 4 | 2015 | 535 | 0.300 |
Why?
|
Polychlorinated Biphenyls | 1 | 2010 | 236 | 0.300 |
Why?
|
Child Welfare | 2 | 2011 | 521 | 0.300 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 3 | 2009 | 638 | 0.300 |
Why?
|
Interferon Type I | 8 | 1991 | 557 | 0.300 |
Why?
|
Growth Substances | 7 | 2000 | 768 | 0.300 |
Why?
|
HIV-2 | 5 | 1991 | 156 | 0.300 |
Why?
|
Colic | 1 | 2007 | 44 | 0.290 |
Why?
|
Foundations | 1 | 2008 | 95 | 0.290 |
Why?
|
Fund Raising | 1 | 2008 | 49 | 0.290 |
Why?
|
Crying | 1 | 2007 | 37 | 0.290 |
Why?
|
Retroviridae Infections | 5 | 1990 | 147 | 0.290 |
Why?
|
Consumer Health Information | 1 | 2010 | 215 | 0.290 |
Why?
|
Physicians | 2 | 2020 | 4583 | 0.290 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 2 | 2019 | 502 | 0.290 |
Why?
|
Homosexuality | 11 | 1989 | 267 | 0.290 |
Why?
|
Cells, Cultured | 24 | 2020 | 18937 | 0.280 |
Why?
|
Tyrosine | 7 | 2004 | 1440 | 0.280 |
Why?
|
Phosphoproteins | 11 | 2011 | 2446 | 0.280 |
Why?
|
Interferon-Stimulated Gene Factor 3 | 1 | 2006 | 10 | 0.280 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 5 | 1998 | 489 | 0.280 |
Why?
|
Phosphotyrosine | 4 | 2001 | 456 | 0.270 |
Why?
|
Bone Marrow Cells | 12 | 2012 | 2409 | 0.270 |
Why?
|
Interleukin-3 | 7 | 1994 | 425 | 0.270 |
Why?
|
Drug Industry | 3 | 2009 | 788 | 0.270 |
Why?
|
Tumor Burden | 1 | 2012 | 1892 | 0.270 |
Why?
|
Antineoplastic Agents | 10 | 2012 | 13635 | 0.270 |
Why?
|
Serine | 1 | 2010 | 830 | 0.270 |
Why?
|
Tinnitus | 1 | 2009 | 196 | 0.270 |
Why?
|
Health Care Reform | 2 | 2020 | 1247 | 0.260 |
Why?
|
Infant Care | 1 | 2007 | 180 | 0.260 |
Why?
|
Emotions | 1 | 2017 | 2740 | 0.250 |
Why?
|
Chromosome Mapping | 2 | 2009 | 4611 | 0.250 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2011 | 2895 | 0.250 |
Why?
|
Patient Participation | 2 | 2017 | 1443 | 0.250 |
Why?
|
Gene Products, env | 1 | 2006 | 250 | 0.250 |
Why?
|
T-Lymphocytes | 10 | 2015 | 10175 | 0.250 |
Why?
|
Child Health Services | 1 | 2011 | 644 | 0.250 |
Why?
|
Congenital Abnormalities | 1 | 2010 | 709 | 0.240 |
Why?
|
Stem Cell Factor | 6 | 1998 | 195 | 0.240 |
Why?
|
Antibodies, Viral | 19 | 1988 | 3150 | 0.240 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 3 | 2005 | 476 | 0.240 |
Why?
|
Culture | 1 | 2009 | 623 | 0.240 |
Why?
|
Legislation, Drug | 1 | 2006 | 214 | 0.240 |
Why?
|
Philosophy, Medical | 1 | 2004 | 79 | 0.240 |
Why?
|
Terminology as Topic | 1 | 2012 | 1528 | 0.230 |
Why?
|
Immunoglobulin E | 1 | 2011 | 1502 | 0.230 |
Why?
|
Actin-Related Protein 2-3 Complex | 2 | 2015 | 61 | 0.230 |
Why?
|
Protein Kinase C | 4 | 2004 | 1202 | 0.230 |
Why?
|
Blotting, Western | 8 | 2012 | 5034 | 0.230 |
Why?
|
Middle East | 1 | 2024 | 231 | 0.230 |
Why?
|
Religion | 2 | 2004 | 372 | 0.220 |
Why?
|
Phosphatidylinositol 3-Kinases | 7 | 2014 | 2864 | 0.220 |
Why?
|
Quality of Health Care | 2 | 2009 | 4321 | 0.220 |
Why?
|
Pseudopodia | 2 | 2015 | 168 | 0.220 |
Why?
|
Decision Making | 1 | 2017 | 3918 | 0.220 |
Why?
|
cdc42 GTP-Binding Protein | 2 | 2015 | 187 | 0.220 |
Why?
|
Clergy | 1 | 2004 | 79 | 0.220 |
Why?
|
Cell Adhesion | 8 | 2010 | 3088 | 0.220 |
Why?
|
Protein Binding | 9 | 2015 | 9345 | 0.220 |
Why?
|
Neovascularization, Physiologic | 1 | 2010 | 1349 | 0.210 |
Why?
|
Protein Biosynthesis | 2 | 2009 | 2100 | 0.210 |
Why?
|
Receptors, Virus | 3 | 1999 | 639 | 0.210 |
Why?
|
Food Hypersensitivity | 1 | 2011 | 726 | 0.210 |
Why?
|
Proteins | 6 | 2000 | 6030 | 0.210 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 4 | 2012 | 145 | 0.210 |
Why?
|
Evidence-Based Medicine | 2 | 2012 | 3680 | 0.200 |
Why?
|
Chemokine CXCL12 | 7 | 2006 | 454 | 0.200 |
Why?
|
Erythropoietin | 6 | 1999 | 719 | 0.200 |
Why?
|
Hematologic Diseases | 4 | 1993 | 496 | 0.200 |
Why?
|
Decision Support Techniques | 1 | 2012 | 1998 | 0.200 |
Why?
|
Macrophages, Alveolar | 4 | 1999 | 411 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-akt | 7 | 2014 | 2456 | 0.200 |
Why?
|
Viral Proteins | 5 | 2007 | 1799 | 0.200 |
Why?
|
Transfection | 9 | 2007 | 5766 | 0.200 |
Why?
|
Medical Records Systems, Computerized | 1 | 2008 | 1191 | 0.200 |
Why?
|
Cytokines | 9 | 2011 | 7373 | 0.190 |
Why?
|
User-Computer Interface | 1 | 2008 | 1397 | 0.190 |
Why?
|
Proto-Oncogene Proteins | 8 | 2005 | 4512 | 0.190 |
Why?
|
Interferon-alpha | 5 | 1994 | 902 | 0.190 |
Why?
|
Ethics, Medical | 1 | 2006 | 783 | 0.190 |
Why?
|
Deoxyguanosine | 1 | 2001 | 92 | 0.190 |
Why?
|
Receptor, Cannabinoid, CB1 | 3 | 2010 | 137 | 0.190 |
Why?
|
Granulocyte Colony-Stimulating Factor | 3 | 1992 | 629 | 0.180 |
Why?
|
Truth Disclosure | 1 | 2005 | 432 | 0.180 |
Why?
|
Thrombopoietin | 4 | 1995 | 226 | 0.180 |
Why?
|
Receptors, HIV | 2 | 1999 | 158 | 0.180 |
Why?
|
Gene Expression | 8 | 2017 | 7568 | 0.180 |
Why?
|
Hydrogen Peroxide | 1 | 2004 | 730 | 0.180 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2007 | 2821 | 0.180 |
Why?
|
Caspases | 3 | 2005 | 878 | 0.170 |
Why?
|
Eukaryotic Initiation Factor-4E | 2 | 2012 | 112 | 0.170 |
Why?
|
Enzyme Precursors | 1 | 2000 | 170 | 0.170 |
Why?
|
Chemokines, CC | 1 | 2001 | 283 | 0.170 |
Why?
|
Mars | 1 | 2000 | 28 | 0.170 |
Why?
|
Cell Survival | 5 | 2007 | 5780 | 0.170 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 4 | 2009 | 682 | 0.170 |
Why?
|
Interleukin-1 | 5 | 1994 | 1248 | 0.170 |
Why?
|
Cell Proliferation | 7 | 2014 | 10432 | 0.170 |
Why?
|
Cystic Fibrosis | 1 | 2009 | 1285 | 0.170 |
Why?
|
Drug Approval | 1 | 2006 | 812 | 0.170 |
Why?
|
Transcription Factor AP-1 | 1 | 2001 | 319 | 0.170 |
Why?
|
Cell Division | 10 | 2007 | 4457 | 0.160 |
Why?
|
Weightlessness | 1 | 2000 | 102 | 0.160 |
Why?
|
Astronauts | 1 | 2000 | 92 | 0.160 |
Why?
|
Aerospace Medicine | 1 | 2000 | 95 | 0.160 |
Why?
|
Receptors, Interleukin | 1 | 2000 | 243 | 0.160 |
Why?
|
Integrin alpha5beta1 | 2 | 2012 | 37 | 0.160 |
Why?
|
Cell Cycle | 1 | 2007 | 2930 | 0.160 |
Why?
|
Neutropenia | 5 | 1993 | 885 | 0.150 |
Why?
|
Chemokine CCL2 | 1 | 2001 | 602 | 0.150 |
Why?
|
United States Food and Drug Administration | 1 | 2006 | 1661 | 0.150 |
Why?
|
Anemia | 6 | 1999 | 1504 | 0.150 |
Why?
|
Cell Line, Tumor | 8 | 2012 | 16967 | 0.150 |
Why?
|
Enzyme Inhibitors | 8 | 2005 | 3705 | 0.150 |
Why?
|
NF-kappa B | 5 | 2019 | 2481 | 0.150 |
Why?
|
Actins | 3 | 2015 | 2050 | 0.150 |
Why?
|
Receptors, Dopamine | 1 | 2019 | 296 | 0.150 |
Why?
|
Early Detection of Cancer | 1 | 2012 | 3196 | 0.150 |
Why?
|
Polymerase Chain Reaction | 10 | 2005 | 6074 | 0.150 |
Why?
|
Internet | 1 | 2010 | 3090 | 0.150 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 1998 | 186 | 0.150 |
Why?
|
GTP-Binding Proteins | 2 | 2000 | 949 | 0.150 |
Why?
|
Simian immunodeficiency virus | 2 | 1999 | 810 | 0.140 |
Why?
|
Feedback, Physiological | 1 | 2020 | 475 | 0.140 |
Why?
|
Space Flight | 1 | 2000 | 216 | 0.140 |
Why?
|
Tumor Necrosis Factor-alpha | 8 | 2001 | 4341 | 0.140 |
Why?
|
Macrophages | 6 | 1998 | 5758 | 0.140 |
Why?
|
Immunological Synapses | 1 | 2017 | 59 | 0.140 |
Why?
|
Mothers | 1 | 2007 | 2194 | 0.140 |
Why?
|
NFATC Transcription Factors | 1 | 2019 | 389 | 0.140 |
Why?
|
Dose-Response Relationship, Drug | 10 | 2012 | 10754 | 0.140 |
Why?
|
Focal Adhesions | 1 | 2017 | 115 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 8 | 2012 | 3800 | 0.130 |
Why?
|
Crk-Associated Substrate Protein | 4 | 2000 | 39 | 0.130 |
Why?
|
Blood Platelets | 3 | 1998 | 2478 | 0.130 |
Why?
|
Calcium | 6 | 2019 | 5717 | 0.130 |
Why?
|
Retinoblastoma-Like Protein p130 | 4 | 2000 | 73 | 0.130 |
Why?
|
Carrier Proteins | 4 | 2015 | 4935 | 0.130 |
Why?
|
Myeloid Cells | 1 | 2001 | 823 | 0.130 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 3 | 2001 | 119 | 0.130 |
Why?
|
HIV Long Terminal Repeat | 4 | 1994 | 85 | 0.130 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2006 | 2291 | 0.130 |
Why?
|
Chemokine CCL4 | 3 | 2001 | 126 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 3 | 2005 | 472 | 0.130 |
Why?
|
Fibroblast Growth Factor 2 | 2 | 1997 | 592 | 0.130 |
Why?
|
Macrophage Inflammatory Proteins | 3 | 2001 | 121 | 0.130 |
Why?
|
Cell Surface Extensions | 1 | 2015 | 67 | 0.130 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2012 | 11736 | 0.130 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2017 | 234 | 0.130 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2017 | 150 | 0.130 |
Why?
|
Caspase 3 | 4 | 2007 | 731 | 0.130 |
Why?
|
Virion | 2 | 2015 | 422 | 0.130 |
Why?
|
Neoplasms | 9 | 2010 | 22131 | 0.130 |
Why?
|
Retroviridae Proteins | 7 | 1989 | 94 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2012 | 988 | 0.120 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2015 | 104 | 0.120 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2017 | 195 | 0.120 |
Why?
|
Drug Evaluation | 8 | 1991 | 641 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2012 | 4570 | 0.120 |
Why?
|
Liver Neoplasms | 4 | 2006 | 4308 | 0.120 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 4 | 2001 | 664 | 0.120 |
Why?
|
Protein Kinases | 4 | 2009 | 1606 | 0.120 |
Why?
|
Endothelium | 1 | 1997 | 764 | 0.120 |
Why?
|
Cyclic AMP | 1 | 2019 | 1463 | 0.120 |
Why?
|
HEK293 Cells | 2 | 2015 | 4269 | 0.120 |
Why?
|
DNA Damage | 2 | 2001 | 2446 | 0.120 |
Why?
|
Clinical Trials as Topic | 10 | 2009 | 7995 | 0.120 |
Why?
|
Flow Cytometry | 6 | 2010 | 5863 | 0.120 |
Why?
|
In Situ Nick-End Labeling | 2 | 2007 | 613 | 0.120 |
Why?
|
Blood Transfusion | 5 | 1997 | 1299 | 0.110 |
Why?
|
Microcirculation | 3 | 2005 | 1272 | 0.110 |
Why?
|
Cysteine Proteinase Inhibitors | 2 | 2007 | 188 | 0.110 |
Why?
|
Practice Management, Medical | 1 | 2016 | 191 | 0.110 |
Why?
|
Base Sequence | 11 | 2012 | 12421 | 0.110 |
Why?
|
Viral Load | 2 | 2007 | 3325 | 0.110 |
Why?
|
Antiviral Agents | 6 | 1991 | 3039 | 0.110 |
Why?
|
Endothelial Cells | 3 | 2014 | 3548 | 0.110 |
Why?
|
MicroRNAs | 2 | 2020 | 3805 | 0.110 |
Why?
|
Myelodysplastic Syndromes | 4 | 2012 | 1394 | 0.110 |
Why?
|
HIV Seropositivity | 6 | 1989 | 959 | 0.110 |
Why?
|
Adaptation, Physiological | 1 | 2000 | 1300 | 0.110 |
Why?
|
Protein Transport | 1 | 2019 | 1966 | 0.110 |
Why?
|
Virus Internalization | 1 | 2017 | 497 | 0.110 |
Why?
|
Risk Assessment | 2 | 2012 | 23972 | 0.110 |
Why?
|
Oligopeptides | 4 | 2005 | 1185 | 0.110 |
Why?
|
Oxidative Stress | 1 | 2004 | 3113 | 0.100 |
Why?
|
Hematopoietic Stem Cell Mobilization | 2 | 2010 | 225 | 0.100 |
Why?
|
Vanadates | 2 | 2004 | 82 | 0.100 |
Why?
|
Antigens, CD | 3 | 2000 | 3998 | 0.100 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2010 | 5319 | 0.100 |
Why?
|
Binding, Competitive | 4 | 2005 | 1141 | 0.100 |
Why?
|
Doxorubicin | 4 | 2012 | 2224 | 0.100 |
Why?
|
Connective Tissue Growth Factor | 1 | 2012 | 91 | 0.100 |
Why?
|
Tretinoin | 3 | 2002 | 519 | 0.100 |
Why?
|
Leukopenia | 2 | 1990 | 213 | 0.100 |
Why?
|
Biological Transport | 1 | 2017 | 2089 | 0.100 |
Why?
|
AIDS-Related Opportunistic Infections | 4 | 2000 | 662 | 0.100 |
Why?
|
Genes, src | 1 | 2012 | 51 | 0.100 |
Why?
|
Treatment Outcome | 3 | 2017 | 64568 | 0.100 |
Why?
|
Bone Marrow Diseases | 1 | 1994 | 233 | 0.100 |
Why?
|
Antigens, Viral | 7 | 1997 | 987 | 0.100 |
Why?
|
Liver | 3 | 2005 | 7512 | 0.100 |
Why?
|
Animals | 30 | 2012 | 168201 | 0.090 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2012 | 242 | 0.090 |
Why?
|
DNA, Viral | 5 | 2007 | 2195 | 0.090 |
Why?
|
Genes, nef | 1 | 1991 | 52 | 0.090 |
Why?
|
Quality of Life | 2 | 2012 | 13347 | 0.090 |
Why?
|
Lymphocytes | 7 | 1991 | 2604 | 0.090 |
Why?
|
Lymphatic Diseases | 3 | 1987 | 320 | 0.090 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1995 | 1169 | 0.090 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2003 | 223 | 0.090 |
Why?
|
Communication | 1 | 2005 | 3849 | 0.090 |
Why?
|
Fatigue | 1 | 1998 | 1550 | 0.090 |
Why?
|
Directories as Topic | 1 | 2010 | 8 | 0.090 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 3 | 1998 | 48 | 0.090 |
Why?
|
Water Pollutants | 1 | 2010 | 24 | 0.090 |
Why?
|
Interleukin-6 | 6 | 2002 | 3206 | 0.090 |
Why?
|
Transcription, Genetic | 3 | 2001 | 7583 | 0.090 |
Why?
|
Chorioallantoic Membrane | 1 | 2010 | 50 | 0.090 |
Why?
|
Lymphoma | 4 | 1999 | 1899 | 0.090 |
Why?
|
Lung Neoplasms | 4 | 2010 | 13382 | 0.090 |
Why?
|
Protein Processing, Post-Translational | 1 | 1998 | 1971 | 0.090 |
Why?
|
src Homology Domains | 2 | 2004 | 361 | 0.090 |
Why?
|
Kinetics | 6 | 2003 | 6370 | 0.090 |
Why?
|
Tetradecanoylphorbol Acetate | 6 | 1994 | 817 | 0.090 |
Why?
|
United States | 9 | 2020 | 72272 | 0.090 |
Why?
|
False Positive Reactions | 1 | 2012 | 957 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2019 | 2894 | 0.090 |
Why?
|
Multiple Myeloma | 1 | 2008 | 5146 | 0.080 |
Why?
|
Microscopy, Confocal | 2 | 2012 | 1970 | 0.080 |
Why?
|
Permeability | 1 | 2012 | 721 | 0.080 |
Why?
|
Lymphatic Vessels | 1 | 2014 | 356 | 0.080 |
Why?
|
Plastics | 1 | 2010 | 117 | 0.080 |
Why?
|
Antineoplastic Agents, Phytogenic | 2 | 2002 | 620 | 0.080 |
Why?
|
Mice | 15 | 2012 | 81368 | 0.080 |
Why?
|
Fas Ligand Protein | 3 | 2005 | 216 | 0.080 |
Why?
|
Fibronectins | 2 | 2005 | 723 | 0.080 |
Why?
|
Consumer Product Safety | 1 | 2010 | 122 | 0.080 |
Why?
|
DNA Primers | 5 | 2012 | 2817 | 0.080 |
Why?
|
Lymphocyte Activation | 4 | 1997 | 5463 | 0.080 |
Why?
|
MAP Kinase Signaling System | 3 | 2001 | 1483 | 0.080 |
Why?
|
HIV Antibodies | 11 | 1994 | 1302 | 0.080 |
Why?
|
Cannabidiol | 1 | 2011 | 118 | 0.080 |
Why?
|
Government | 1 | 2010 | 160 | 0.080 |
Why?
|
Histamine | 1 | 2011 | 499 | 0.080 |
Why?
|
Biological Factors | 1 | 1990 | 157 | 0.080 |
Why?
|
Cell Transformation, Viral | 1 | 1990 | 526 | 0.080 |
Why?
|
Patient Access to Records | 1 | 2010 | 119 | 0.080 |
Why?
|
Male | 52 | 2017 | 360358 | 0.080 |
Why?
|
Antigens, Surface | 2 | 1992 | 1605 | 0.080 |
Why?
|
GRB2 Adaptor Protein | 2 | 2000 | 101 | 0.080 |
Why?
|
Thymidine | 4 | 1992 | 297 | 0.080 |
Why?
|
Acrylic Resins | 1 | 2009 | 135 | 0.080 |
Why?
|
Opportunistic Infections | 8 | 1991 | 376 | 0.080 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2012 | 678 | 0.080 |
Why?
|
Viral Core Proteins | 5 | 1990 | 161 | 0.080 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2012 | 630 | 0.080 |
Why?
|
Professional Role | 1 | 2011 | 313 | 0.080 |
Why?
|
raf Kinases | 1 | 2009 | 118 | 0.080 |
Why?
|
History, Ancient | 1 | 2009 | 212 | 0.080 |
Why?
|
Chloramphenicol O-Acetyltransferase | 4 | 1999 | 221 | 0.080 |
Why?
|
Chick Embryo | 1 | 2010 | 982 | 0.080 |
Why?
|
Mitochondria | 3 | 2012 | 3619 | 0.080 |
Why?
|
Dideoxynucleosides | 1 | 1988 | 135 | 0.080 |
Why?
|
Host-Pathogen Interactions | 1 | 2017 | 1454 | 0.080 |
Why?
|
Stromal Cells | 2 | 2010 | 1329 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor B | 2 | 1997 | 25 | 0.080 |
Why?
|
Lymphokines | 3 | 2000 | 925 | 0.070 |
Why?
|
Infant | 2 | 2007 | 36152 | 0.070 |
Why?
|
Interleukin-2 | 2 | 1992 | 1887 | 0.070 |
Why?
|
Death | 1 | 2012 | 674 | 0.070 |
Why?
|
Cannabinoids | 2 | 2010 | 172 | 0.070 |
Why?
|
Female | 37 | 2017 | 392148 | 0.070 |
Why?
|
Peanut Hypersensitivity | 1 | 2011 | 219 | 0.070 |
Why?
|
Molecular Structure | 2 | 2007 | 1878 | 0.070 |
Why?
|
History, 16th Century | 1 | 2007 | 70 | 0.070 |
Why?
|
Receptors, Cannabinoid | 1 | 2007 | 43 | 0.070 |
Why?
|
Economics, Pharmaceutical | 1 | 2008 | 87 | 0.070 |
Why?
|
HIV Core Protein p24 | 4 | 1991 | 245 | 0.070 |
Why?
|
Ethics, Pharmacy | 1 | 2006 | 6 | 0.070 |
Why?
|
Research Design | 3 | 2008 | 6174 | 0.070 |
Why?
|
HIV Antigens | 6 | 1990 | 325 | 0.070 |
Why?
|
MAP Kinase Kinase 4 | 2 | 1997 | 146 | 0.070 |
Why?
|
RNA, Viral | 4 | 2002 | 2838 | 0.070 |
Why?
|
Leukocyte Count | 8 | 1991 | 1597 | 0.070 |
Why?
|
Cost Control | 1 | 2009 | 627 | 0.070 |
Why?
|
G2 Phase | 1 | 2007 | 136 | 0.070 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 2005 | 1738 | 0.070 |
Why?
|
Molecular Sequence Data | 10 | 2001 | 17629 | 0.070 |
Why?
|
DNA | 6 | 2005 | 7196 | 0.070 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 614 | 0.070 |
Why?
|
Endothelial Growth Factors | 2 | 2000 | 673 | 0.070 |
Why?
|
Ovarian Neoplasms | 2 | 2000 | 4849 | 0.070 |
Why?
|
Antigens, CD34 | 2 | 1998 | 658 | 0.070 |
Why?
|
Aflatoxin B1 | 3 | 1997 | 17 | 0.070 |
Why?
|
Commerce | 1 | 2011 | 608 | 0.070 |
Why?
|
Mice, SCID | 2 | 2010 | 2625 | 0.070 |
Why?
|
Sexual Behavior | 4 | 1989 | 2187 | 0.070 |
Why?
|
Drug Therapy | 1 | 2009 | 503 | 0.060 |
Why?
|
Consensus Sequence | 1 | 2006 | 364 | 0.060 |
Why?
|
Muscular Diseases | 1 | 1990 | 553 | 0.060 |
Why?
|
Public Policy | 1 | 2010 | 557 | 0.060 |
Why?
|
Viral Structural Proteins | 1 | 2005 | 95 | 0.060 |
Why?
|
Adjuvants, Immunologic | 1 | 1991 | 990 | 0.060 |
Why?
|
Aging | 1 | 2004 | 8699 | 0.060 |
Why?
|
Adult | 36 | 2012 | 220969 | 0.060 |
Why?
|
Interferons | 1 | 1989 | 703 | 0.060 |
Why?
|
Ligands | 3 | 2005 | 3268 | 0.060 |
Why?
|
Integrin alpha3beta1 | 1 | 2005 | 53 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2016 | 7389 | 0.060 |
Why?
|
Immune System | 1 | 2011 | 791 | 0.060 |
Why?
|
Plasmids | 3 | 2005 | 2265 | 0.060 |
Why?
|
Vinca Alkaloids | 1 | 1985 | 36 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3451 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 3 | 1991 | 974 | 0.060 |
Why?
|
Trans-Activators | 2 | 2007 | 2852 | 0.060 |
Why?
|
Anecdotes as Topic | 1 | 2004 | 56 | 0.060 |
Why?
|
Lipopolysaccharides | 4 | 2010 | 2202 | 0.060 |
Why?
|
Leukemia, Monocytic, Acute | 2 | 1998 | 58 | 0.060 |
Why?
|
Cyclohexanols | 3 | 2010 | 126 | 0.060 |
Why?
|
Erythropoiesis | 1 | 1988 | 684 | 0.060 |
Why?
|
Cattle | 1 | 2010 | 3841 | 0.060 |
Why?
|
Immediate-Early Proteins | 1 | 2007 | 444 | 0.060 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2007 | 717 | 0.060 |
Why?
|
Drug Therapy, Combination | 5 | 1992 | 6305 | 0.060 |
Why?
|
Epidermal Growth Factor | 1 | 2007 | 699 | 0.060 |
Why?
|
Dogs | 2 | 1999 | 3838 | 0.060 |
Why?
|
Retroviridae Proteins, Oncogenic | 1 | 2004 | 74 | 0.060 |
Why?
|
Hepatitis C | 2 | 2005 | 1579 | 0.060 |
Why?
|
Oncogene Protein v-akt | 1 | 2004 | 129 | 0.060 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2008 | 794 | 0.060 |
Why?
|
Focal Adhesion Kinase 1 | 2 | 2001 | 120 | 0.060 |
Why?
|
Gene Expression Regulation | 3 | 2020 | 11874 | 0.060 |
Why?
|
RNA Interference | 1 | 2012 | 2830 | 0.060 |
Why?
|
Costs and Cost Analysis | 2 | 2009 | 1663 | 0.060 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 2 | 2001 | 186 | 0.060 |
Why?
|
Imines | 1 | 2003 | 27 | 0.060 |
Why?
|
Quinuclidines | 1 | 2003 | 24 | 0.060 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 4 | 1989 | 897 | 0.050 |
Why?
|
Fibroblasts | 2 | 1992 | 4137 | 0.050 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2011 | 2057 | 0.050 |
Why?
|
Tissue Plasminogen Activator | 1 | 1989 | 1163 | 0.050 |
Why?
|
Culture Media, Serum-Free | 2 | 2005 | 148 | 0.050 |
Why?
|
Clinical Protocols | 1 | 2009 | 1437 | 0.050 |
Why?
|
Peptide Fragments | 2 | 2014 | 5110 | 0.050 |
Why?
|
RNA-Directed DNA Polymerase | 3 | 1989 | 225 | 0.050 |
Why?
|
Autophagy | 1 | 2011 | 1326 | 0.050 |
Why?
|
Substance Abuse, Intravenous | 1 | 2008 | 529 | 0.050 |
Why?
|
Breast Neoplasms | 5 | 2012 | 20988 | 0.050 |
Why?
|
Prostate-Specific Antigen | 1 | 2012 | 2465 | 0.050 |
Why?
|
Gene Products, nef | 1 | 2002 | 100 | 0.050 |
Why?
|
Immunoprecipitation | 1 | 2005 | 876 | 0.050 |
Why?
|
Amino Acid Motifs | 1 | 2005 | 927 | 0.050 |
Why?
|
Benchmarking | 1 | 2009 | 1045 | 0.050 |
Why?
|
Neoplasm Proteins | 4 | 2000 | 3607 | 0.050 |
Why?
|
Career Choice | 1 | 2009 | 756 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
Language | 1 | 2012 | 1541 | 0.050 |
Why?
|
Genes, p53 | 2 | 1997 | 712 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
Home Care Services | 1 | 2009 | 648 | 0.050 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2004 | 412 | 0.050 |
Why?
|
Workload | 1 | 2008 | 844 | 0.050 |
Why?
|
Cytopathogenic Effect, Viral | 2 | 1993 | 151 | 0.050 |
Why?
|
HIV Envelope Protein gp160 | 2 | 2000 | 92 | 0.050 |
Why?
|
Proteoglycans | 1 | 2005 | 803 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-crk | 1 | 2001 | 13 | 0.050 |
Why?
|
Open Reading Frames | 1 | 2005 | 813 | 0.050 |
Why?
|
STAT2 Transcription Factor | 1 | 2001 | 27 | 0.050 |
Why?
|
Documentation | 1 | 2008 | 895 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2003 | 2872 | 0.050 |
Why?
|
Tyrphostins | 1 | 2001 | 63 | 0.050 |
Why?
|
Mammography | 1 | 2012 | 2430 | 0.050 |
Why?
|
Platelet Activation | 2 | 1995 | 646 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2009 | 1614 | 0.050 |
Why?
|
STAT4 Transcription Factor | 1 | 2001 | 93 | 0.050 |
Why?
|
Chemokine CCL3 | 1 | 2001 | 84 | 0.050 |
Why?
|
Administration, Oral | 5 | 2002 | 4010 | 0.050 |
Why?
|
Colony-Forming Units Assay | 2 | 1994 | 351 | 0.050 |
Why?
|
Cloning, Molecular | 3 | 1995 | 4172 | 0.050 |
Why?
|
Fluorescent Antibody Technique | 4 | 2012 | 2467 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2012 | 2812 | 0.040 |
Why?
|
Depression, Chemical | 2 | 1991 | 184 | 0.040 |
Why?
|
Weightlessness Countermeasures | 1 | 2000 | 5 | 0.040 |
Why?
|
Skin Neoplasms | 3 | 2005 | 5812 | 0.040 |
Why?
|
Disease Outbreaks | 3 | 1987 | 1748 | 0.040 |
Why?
|
Gravity, Altered | 1 | 2000 | 10 | 0.040 |
Why?
|
Receptors, Interleukin-8A | 1 | 2000 | 47 | 0.040 |
Why?
|
United States National Aeronautics and Space Administration | 1 | 2000 | 15 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2000 | 120 | 0.040 |
Why?
|
Receptors, Interleukin-8B | 1 | 2000 | 58 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8645 | 0.040 |
Why?
|
Cosmic Radiation | 1 | 2000 | 24 | 0.040 |
Why?
|
Membrane Glycoproteins | 3 | 2005 | 3688 | 0.040 |
Why?
|
Remission Induction | 3 | 1991 | 2391 | 0.040 |
Why?
|
Antibodies, Monoclonal | 3 | 1993 | 9172 | 0.040 |
Why?
|
Epoetin Alfa | 1 | 1999 | 78 | 0.040 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2000 | 748 | 0.040 |
Why?
|
Drug Administration Schedule | 5 | 2000 | 4845 | 0.040 |
Why?
|
Cell Cycle Proteins | 2 | 2011 | 3447 | 0.040 |
Why?
|
Hepatitis C, Chronic | 1 | 2008 | 1018 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2001 | 426 | 0.040 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2001 | 156 | 0.040 |
Why?
|
Umbilical Veins | 2 | 2006 | 426 | 0.040 |
Why?
|
Culture Media, Conditioned | 1 | 2001 | 522 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9461 | 0.040 |
Why?
|
Transcriptional Activation | 2 | 2005 | 1755 | 0.040 |
Why?
|
Patient-Centered Care | 1 | 2009 | 1418 | 0.040 |
Why?
|
Wound Healing | 1 | 2010 | 2802 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 485 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2001 | 13441 | 0.040 |
Why?
|
Immunomagnetic Separation | 1 | 1998 | 79 | 0.040 |
Why?
|
Pharmaceutical Preparations | 1 | 2006 | 1086 | 0.040 |
Why?
|
Chemokine CXCL10 | 1 | 1999 | 309 | 0.040 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 1998 | 94 | 0.040 |
Why?
|
Interprofessional Relations | 1 | 2004 | 990 | 0.040 |
Why?
|
Immunosorbent Techniques | 1 | 1998 | 174 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3792 | 0.040 |
Why?
|
Up-Regulation | 2 | 2005 | 4117 | 0.040 |
Why?
|
Janus Kinase 2 | 1 | 2001 | 560 | 0.040 |
Why?
|
Heparin | 1 | 2005 | 1632 | 0.040 |
Why?
|
Oncostatin M | 1 | 1997 | 42 | 0.040 |
Why?
|
Gene Products, rev | 1 | 1997 | 29 | 0.040 |
Why?
|
Skin | 2 | 2007 | 4473 | 0.040 |
Why?
|
Lymphedema | 1 | 2004 | 523 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 2008 | 1926 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-fyn | 1 | 1997 | 110 | 0.040 |
Why?
|
Saliva | 3 | 1986 | 828 | 0.040 |
Why?
|
B-Lymphocytes | 3 | 1998 | 4745 | 0.040 |
Why?
|
Extracellular Matrix | 1 | 2005 | 1718 | 0.030 |
Why?
|
DNA Adducts | 1 | 1997 | 94 | 0.030 |
Why?
|
Social Isolation | 1 | 2000 | 364 | 0.030 |
Why?
|
Random Allocation | 4 | 1991 | 2392 | 0.030 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1997 | 427 | 0.030 |
Why?
|
Recombination, Genetic | 2 | 1995 | 1519 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 1997 | 2546 | 0.030 |
Why?
|
Hematinics | 1 | 1999 | 282 | 0.030 |
Why?
|
Bone Marrow Transplantation | 3 | 1990 | 2690 | 0.030 |
Why?
|
Isoniazid | 1 | 1978 | 283 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 1 | 2001 | 829 | 0.030 |
Why?
|
Hemoglobins | 3 | 1991 | 1524 | 0.030 |
Why?
|
Muridae | 1 | 1995 | 56 | 0.030 |
Why?
|
Rifampin | 1 | 1978 | 339 | 0.030 |
Why?
|
Mutagenesis | 1 | 2000 | 1230 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2012 | 18221 | 0.030 |
Why?
|
Air Pollutants | 1 | 2010 | 2893 | 0.030 |
Why?
|
Rectal Neoplasms | 1 | 1985 | 1156 | 0.030 |
Why?
|
Middle Aged | 19 | 2012 | 220584 | 0.030 |
Why?
|
Hybrid Cells | 1 | 1995 | 422 | 0.030 |
Why?
|
Pediatrics | 1 | 2011 | 3588 | 0.030 |
Why?
|
Cell Communication | 2 | 2010 | 1654 | 0.030 |
Why?
|
Environmental Health | 1 | 1998 | 288 | 0.030 |
Why?
|
Health Care Costs | 1 | 2009 | 3238 | 0.030 |
Why?
|
Immunoenzyme Techniques | 2 | 2010 | 1703 | 0.030 |
Why?
|
Transforming Growth Factor beta | 2 | 1994 | 1963 | 0.030 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 1999 | 541 | 0.030 |
Why?
|
CD4 Immunoadhesins | 2 | 1991 | 12 | 0.030 |
Why?
|
DNA, Complementary | 2 | 1995 | 1989 | 0.030 |
Why?
|
Drug Tolerance | 2 | 2002 | 367 | 0.030 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1997 | 412 | 0.030 |
Why?
|
Receptors, Cytokine | 1 | 1995 | 257 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2010 | 14389 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2009 | 3879 | 0.030 |
Why?
|
Interferon-gamma | 3 | 1990 | 3145 | 0.030 |
Why?
|
Species Specificity | 1 | 1999 | 2411 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 1404 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2004 | 2570 | 0.030 |
Why?
|
Paclitaxel | 1 | 2002 | 1730 | 0.030 |
Why?
|
Receptors, Colony-Stimulating Factor | 1 | 1994 | 50 | 0.030 |
Why?
|
Erythrocyte Transfusion | 1 | 1999 | 568 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 1995 | 750 | 0.030 |
Why?
|
Mice, Inbred C57BL | 4 | 2010 | 22115 | 0.030 |
Why?
|
Pyrimidines | 2 | 2004 | 3027 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 2 | 1995 | 2747 | 0.030 |
Why?
|
Receptors, Retinoic Acid | 1 | 1994 | 224 | 0.030 |
Why?
|
Quality Improvement | 1 | 2009 | 3797 | 0.030 |
Why?
|
RNA, Messenger | 4 | 2010 | 12758 | 0.030 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 1997 | 544 | 0.030 |
Why?
|
Receptors, Very Late Antigen | 1 | 1993 | 74 | 0.030 |
Why?
|
Lymphoma, B-Cell | 1 | 2000 | 938 | 0.030 |
Why?
|
Ganciclovir | 1 | 1994 | 252 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2001 | 1662 | 0.030 |
Why?
|
Erythroid Precursor Cells | 1 | 1994 | 212 | 0.030 |
Why?
|
Collagen | 1 | 2001 | 2634 | 0.030 |
Why?
|
Robotics | 1 | 2000 | 816 | 0.030 |
Why?
|
Ceramides | 1 | 1994 | 200 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2006 | 4174 | 0.030 |
Why?
|
Time Factors | 5 | 2005 | 39913 | 0.030 |
Why?
|
Gene Products, gag | 2 | 1990 | 312 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 1985 | 2533 | 0.030 |
Why?
|
Jurkat Cells | 2 | 2006 | 740 | 0.030 |
Why?
|
Cytomegalovirus | 1 | 1997 | 749 | 0.030 |
Why?
|
Ilium | 1 | 1993 | 154 | 0.030 |
Why?
|
Mutation | 5 | 2005 | 30016 | 0.030 |
Why?
|
Conserved Sequence | 1 | 1995 | 1162 | 0.030 |
Why?
|
Gene Expression Regulation, Viral | 2 | 1991 | 433 | 0.030 |
Why?
|
Benzo(a)pyrene | 1 | 1991 | 27 | 0.020 |
Why?
|
Dependovirus | 1 | 1997 | 712 | 0.020 |
Why?
|
Granulocytes | 1 | 1994 | 551 | 0.020 |
Why?
|
Ploidies | 1 | 1992 | 285 | 0.020 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 1993 | 378 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2004 | 2527 | 0.020 |
Why?
|
RNA | 2 | 1992 | 2713 | 0.020 |
Why?
|
Platelet Count | 2 | 1991 | 780 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2004 | 3599 | 0.020 |
Why?
|
Side-Population Cells | 1 | 2010 | 12 | 0.020 |
Why?
|
Thrombocytopenia | 3 | 1989 | 1182 | 0.020 |
Why?
|
Polyunsaturated Alkamides | 1 | 2010 | 29 | 0.020 |
Why?
|
Trisomy | 1 | 2012 | 260 | 0.020 |
Why?
|
Organ Specificity | 1 | 1995 | 1964 | 0.020 |
Why?
|
Glycerides | 1 | 2010 | 67 | 0.020 |
Why?
|
Rabbits | 1 | 1997 | 4770 | 0.020 |
Why?
|
Brain | 2 | 1995 | 27101 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2012 | 453 | 0.020 |
Why?
|
Indoles | 2 | 2010 | 1830 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2000 | 3492 | 0.020 |
Why?
|
Hypocalcemia | 1 | 1991 | 200 | 0.020 |
Why?
|
Giant Cells | 1 | 1990 | 188 | 0.020 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 1991 | 284 | 0.020 |
Why?
|
Vinblastine | 2 | 1991 | 488 | 0.020 |
Why?
|
Naphthalenes | 1 | 2010 | 198 | 0.020 |
Why?
|
Amidohydrolases | 1 | 2010 | 158 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2012 | 11106 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 1990 | 861 | 0.020 |
Why?
|
Herpesvirus 4, Human | 2 | 1986 | 1077 | 0.020 |
Why?
|
Adsorption | 1 | 1989 | 197 | 0.020 |
Why?
|
Ionomycin | 1 | 1989 | 110 | 0.020 |
Why?
|
Cell Lineage | 1 | 1998 | 2554 | 0.020 |
Why?
|
Phytohemagglutinins | 1 | 1989 | 165 | 0.020 |
Why?
|
Ethers | 1 | 1989 | 73 | 0.020 |
Why?
|
Zalcitabine | 1 | 1988 | 43 | 0.020 |
Why?
|
HIV Envelope Protein gp41 | 1 | 1991 | 303 | 0.020 |
Why?
|
Benzoxazines | 1 | 2010 | 316 | 0.020 |
Why?
|
Aged | 7 | 2012 | 169042 | 0.020 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1990 | 355 | 0.020 |
Why?
|
Tetanus Toxoid | 1 | 1989 | 188 | 0.020 |
Why?
|
Child, Preschool | 2 | 2011 | 42188 | 0.020 |
Why?
|
Agranulocytosis | 1 | 1988 | 97 | 0.020 |
Why?
|
Neutralization Tests | 2 | 1988 | 725 | 0.020 |
Why?
|
Clone Cells | 1 | 1992 | 1657 | 0.020 |
Why?
|
Solubility | 1 | 1990 | 1089 | 0.020 |
Why?
|
Fetus | 1 | 1995 | 1862 | 0.020 |
Why?
|
Immunoglobulin G | 3 | 1990 | 4533 | 0.020 |
Why?
|
Suramin | 1 | 1987 | 34 | 0.020 |
Why?
|
Pan troglodytes | 1 | 1988 | 223 | 0.020 |
Why?
|
Peripheral Nervous System Diseases | 2 | 1991 | 709 | 0.020 |
Why?
|
Mannose-Binding Lectins | 2 | 1989 | 96 | 0.020 |
Why?
|
RNA Splicing | 1 | 1992 | 898 | 0.020 |
Why?
|
Sex Counseling | 1 | 1987 | 18 | 0.020 |
Why?
|
Depression | 1 | 2007 | 8132 | 0.020 |
Why?
|
Morpholines | 1 | 2010 | 581 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2010 | 632 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2010 | 694 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2007 | 26180 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1991 | 790 | 0.020 |
Why?
|
Stem Cell Niche | 1 | 2010 | 344 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 1990 | 8516 | 0.020 |
Why?
|
Aflatoxins | 1 | 1986 | 12 | 0.020 |
Why?
|
Cartilage | 1 | 1990 | 806 | 0.020 |
Why?
|
Eosinophils | 1 | 1991 | 953 | 0.020 |
Why?
|
Cricetinae | 1 | 1990 | 2424 | 0.020 |
Why?
|
Receptors, Fc | 1 | 1990 | 534 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2001 | 5789 | 0.020 |
Why?
|
Virosomes | 1 | 2005 | 5 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 1997 | 2553 | 0.020 |
Why?
|
Blood Coagulation Disorders | 1 | 1989 | 350 | 0.020 |
Why?
|
Child | 3 | 2011 | 80079 | 0.020 |
Why?
|
Health Promotion | 1 | 1998 | 2206 | 0.020 |
Why?
|
Cell Migration Inhibition | 1 | 2005 | 97 | 0.020 |
Why?
|
Antigens, Differentiation | 1 | 1989 | 908 | 0.020 |
Why?
|
Tumor Necrosis Factors | 1 | 2005 | 107 | 0.020 |
Why?
|
Cyclohexanes | 1 | 2006 | 152 | 0.020 |
Why?
|
False Negative Reactions | 1 | 1986 | 573 | 0.020 |
Why?
|
Nerve Tissue | 1 | 1985 | 78 | 0.020 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 1 | 2005 | 33 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 3 | 2002 | 3730 | 0.020 |
Why?
|
Vaccines, Synthetic | 1 | 1988 | 612 | 0.020 |
Why?
|
DNA Replication | 1 | 1992 | 1414 | 0.020 |
Why?
|
Peptides | 1 | 1997 | 4354 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2000 | 2574 | 0.020 |
Why?
|
Vitronectin | 1 | 2005 | 40 | 0.020 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2005 | 88 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 1999 | 2894 | 0.020 |
Why?
|
Nervous System Diseases | 2 | 1985 | 1662 | 0.020 |
Why?
|
Drug Resistance | 1 | 1991 | 1594 | 0.020 |
Why?
|
Cell Differentiation | 3 | 1992 | 11514 | 0.020 |
Why?
|
Biology | 1 | 1987 | 290 | 0.010 |
Why?
|
Mitochondria, Liver | 1 | 2005 | 190 | 0.010 |
Why?
|
Pancreatitis | 1 | 1991 | 1097 | 0.010 |
Why?
|
Integrin alphaVbeta3 | 1 | 2005 | 105 | 0.010 |
Why?
|
Prognosis | 1 | 2005 | 29600 | 0.010 |
Why?
|
Endocytosis | 2 | 1990 | 955 | 0.010 |
Why?
|
Community Health Centers | 1 | 1988 | 460 | 0.010 |
Why?
|
Adenosine Diphosphate | 2 | 1995 | 422 | 0.010 |
Why?
|
Endonucleases | 1 | 1987 | 371 | 0.010 |
Why?
|
Immunization | 1 | 1988 | 1217 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2001 | 9586 | 0.010 |
Why?
|
Sulfamethoxazole | 1 | 1983 | 51 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 1991 | 2913 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2011 | 1403 | 0.010 |
Why?
|
Down-Regulation | 1 | 1991 | 2915 | 0.010 |
Why?
|
Pulmonary Alveoli | 1 | 1986 | 652 | 0.010 |
Why?
|
Bacterial Infections | 1 | 1991 | 1389 | 0.010 |
Why?
|
Trimethoprim | 1 | 1983 | 78 | 0.010 |
Why?
|
Immunoassay | 1 | 1987 | 744 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 2137 | 0.010 |
Why?
|
Environmental Exposure | 1 | 1998 | 4483 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2208 | 0.010 |
Why?
|
Cerebrospinal Fluid | 1 | 1985 | 544 | 0.010 |
Why?
|
Immunoglobulins | 1 | 1986 | 850 | 0.010 |
Why?
|
Antigens | 1 | 1988 | 1441 | 0.010 |
Why?
|
Blood Donors | 1 | 1984 | 345 | 0.010 |
Why?
|
Needles | 1 | 1985 | 450 | 0.010 |
Why?
|
Cell Death | 1 | 2008 | 1677 | 0.010 |
Why?
|
Blood Coagulation | 1 | 1988 | 1154 | 0.010 |
Why?
|
Jews | 1 | 1984 | 356 | 0.010 |
Why?
|
Phenols | 1 | 2006 | 516 | 0.010 |
Why?
|
Substance-Related Disorders | 3 | 1989 | 4416 | 0.010 |
Why?
|
Carrier State | 1 | 1985 | 522 | 0.010 |
Why?
|
Africa | 1 | 1984 | 710 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1984 | 1623 | 0.010 |
Why?
|
Membrane Proteins | 1 | 1998 | 7847 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 1999 | 15828 | 0.010 |
Why?
|
DNA Helicases | 1 | 1987 | 851 | 0.010 |
Why?
|
Incidence | 1 | 1999 | 21337 | 0.010 |
Why?
|
Tumor Virus Infections | 1 | 1984 | 438 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 1994 | 4571 | 0.010 |
Why?
|
Antibodies | 1 | 1989 | 2414 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 1993 | 39063 | 0.010 |
Why?
|
Receptors, Interleukin-6 | 1 | 2002 | 224 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2010 | 2644 | 0.010 |
Why?
|
Oncogenes | 1 | 1986 | 1221 | 0.010 |
Why?
|
Drug Eruptions | 1 | 1983 | 335 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2002 | 836 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 1999 | 6925 | 0.010 |
Why?
|
Risk | 3 | 1986 | 9604 | 0.010 |
Why?
|
Gels | 1 | 2000 | 420 | 0.010 |
Why?
|
Molecular Weight | 3 | 1987 | 2185 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1986 | 1866 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 1986 | 2897 | 0.010 |
Why?
|
Blood-Brain Barrier | 1 | 1985 | 1027 | 0.010 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 1982 | 547 | 0.010 |
Why?
|
Growth Inhibitors | 1 | 2000 | 375 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 2002 | 753 | 0.010 |
Why?
|
Health Transition | 1 | 1998 | 35 | 0.010 |
Why?
|
Administration, Cutaneous | 1 | 2000 | 712 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 1989 | 3077 | 0.010 |
Why?
|
Military Personnel | 1 | 1987 | 1245 | 0.010 |
Why?
|
rev Gene Products, Human Immunodeficiency Virus | 1 | 1997 | 27 | 0.010 |
Why?
|
Cytochalasin B | 1 | 1997 | 74 | 0.010 |
Why?
|
Neuregulins | 1 | 1997 | 36 | 0.010 |
Why?
|
Occupational Diseases | 1 | 1985 | 1490 | 0.010 |
Why?
|
Safety | 1 | 2002 | 1149 | 0.010 |
Why?
|
Survival Rate | 3 | 2002 | 12719 | 0.010 |
Why?
|
Europe | 1 | 1984 | 3413 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2002 | 2063 | 0.010 |
Why?
|
Precipitin Tests | 2 | 1989 | 813 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1992 | 14648 | 0.010 |
Why?
|
Dementia | 3 | 1985 | 2680 | 0.010 |
Why?
|
Lymph Nodes | 1 | 1988 | 3461 | 0.010 |
Why?
|
Palatine Tonsil | 1 | 1997 | 193 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 1997 | 574 | 0.010 |
Why?
|
Immunity, Cellular | 2 | 1994 | 1550 | 0.010 |
Why?
|
Biopsy | 1 | 1987 | 6762 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 2002 | 2567 | 0.010 |
Why?
|
Immunohistochemistry | 3 | 1997 | 11069 | 0.010 |
Why?
|
Liver Transplantation | 1 | 1987 | 2329 | 0.010 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 1997 | 755 | 0.010 |
Why?
|
Boston | 1 | 1988 | 9313 | 0.010 |
Why?
|
Thromboxane B2 | 1 | 1994 | 143 | 0.010 |
Why?
|
Double-Blind Method | 4 | 1990 | 12334 | 0.010 |
Why?
|
Receptors, Thrombopoietin | 1 | 1995 | 160 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 1997 | 1433 | 0.010 |
Why?
|
Immunotherapy | 2 | 1994 | 4642 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 1992 | 20074 | 0.010 |
Why?
|
Pneumonia, Pneumocystis | 2 | 1987 | 242 | 0.010 |
Why?
|
Stereoisomerism | 1 | 1994 | 613 | 0.010 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 1995 | 433 | 0.010 |
Why?
|
Genes, Reporter | 1 | 1997 | 1525 | 0.010 |
Why?
|
Prospective Studies | 3 | 1987 | 54360 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1994 | 866 | 0.010 |
Why?
|
Platelet Aggregation | 1 | 1995 | 771 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5672 | 0.010 |
Why?
|
Fibrinogen | 1 | 1995 | 887 | 0.010 |
Why?
|
Cell Fusion | 1 | 1992 | 294 | 0.010 |
Why?
|
Lung | 1 | 1990 | 9998 | 0.010 |
Why?
|
TATA Box | 1 | 1991 | 127 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 1987 | 4236 | 0.010 |
Why?
|
DNA Fingerprinting | 1 | 1991 | 114 | 0.010 |
Why?
|
Algorithms | 1 | 2012 | 14018 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1991 | 416 | 0.010 |
Why?
|
Transcription Factor TFIID | 1 | 1991 | 150 | 0.010 |
Why?
|
Biological Availability | 1 | 1991 | 389 | 0.010 |
Why?
|
Feedback | 1 | 1994 | 790 | 0.010 |
Why?
|
Epinephrine | 1 | 1994 | 792 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1994 | 1349 | 0.010 |
Why?
|
Disease Progression | 1 | 2008 | 13495 | 0.010 |
Why?
|
Cytomegalovirus Infections | 1 | 1997 | 828 | 0.010 |
Why?
|
Risk Factors | 2 | 1988 | 74115 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 1994 | 727 | 0.010 |
Why?
|
Primary Prevention | 1 | 1998 | 1185 | 0.010 |
Why?
|
Fluorouracil | 1 | 1995 | 1642 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 1991 | 555 | 0.010 |
Why?
|
Drug Synergism | 1 | 1994 | 1755 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1994 | 2261 | 0.010 |
Why?
|
Immunity, Maternally-Acquired | 1 | 1990 | 111 | 0.010 |
Why?
|
Serotonin | 1 | 1994 | 1041 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1994 | 2178 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1991 | 1376 | 0.010 |
Why?
|
Pyrazoles | 1 | 2000 | 2008 | 0.010 |
Why?
|
Cytoplasm | 1 | 1994 | 1503 | 0.010 |
Why?
|
Pregnancy | 2 | 1990 | 29868 | 0.010 |
Why?
|
Glycoproteins | 1 | 1997 | 2200 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 1984 | 11116 | 0.010 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 1990 | 302 | 0.000 |
Why?
|
Hematocrit | 1 | 1990 | 623 | 0.000 |
Why?
|
Chromatography, Affinity | 1 | 1989 | 532 | 0.000 |
Why?
|
Immune Sera | 1 | 1988 | 605 | 0.000 |
Why?
|
Inflammation | 1 | 2008 | 10760 | 0.000 |
Why?
|
Bisexuality | 1 | 1989 | 294 | 0.000 |
Why?
|
Genetic Vectors | 1 | 1997 | 3392 | 0.000 |
Why?
|
Erythrocyte Count | 1 | 1987 | 157 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2012 | 58894 | 0.000 |
Why?
|
Chromosome Deletion | 1 | 1991 | 1386 | 0.000 |
Why?
|
Rosette Formation | 1 | 1986 | 152 | 0.000 |
Why?
|
Immunoglobulin A, Secretory | 1 | 1986 | 104 | 0.000 |
Why?
|
Health Policy | 1 | 1998 | 2682 | 0.000 |
Why?
|
Genes, Viral | 1 | 1987 | 649 | 0.000 |
Why?
|
Mutagens | 1 | 1986 | 179 | 0.000 |
Why?
|
Immunologic Techniques | 1 | 1985 | 212 | 0.000 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 1988 | 621 | 0.000 |
Why?
|
Infusions, Intravenous | 1 | 1990 | 2214 | 0.000 |
Why?
|
Superoxides | 1 | 1986 | 387 | 0.000 |
Why?
|
Sexual Partners | 1 | 1989 | 800 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1988 | 2561 | 0.000 |
Why?
|
Vitamin B 12 | 1 | 1987 | 524 | 0.000 |
Why?
|
Integrases | 1 | 1987 | 518 | 0.000 |
Why?
|
Meningitis | 1 | 1985 | 217 | 0.000 |
Why?
|
Spectrometry, Fluorescence | 1 | 1986 | 685 | 0.000 |
Why?
|
Cholesterol Esters | 1 | 1983 | 73 | 0.000 |
Why?
|
Macaca mulatta | 1 | 1990 | 2328 | 0.000 |
Why?
|
Personnel, Hospital | 1 | 1985 | 285 | 0.000 |
Why?
|
Antibody Specificity | 1 | 1985 | 1058 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 1990 | 10199 | 0.000 |
Why?
|
Spinal Cord Diseases | 1 | 1985 | 291 | 0.000 |
Why?
|
Binding Sites | 1 | 1991 | 6051 | 0.000 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1986 | 1540 | 0.000 |
Why?
|
Receptors, LDL | 1 | 1983 | 488 | 0.000 |
Why?
|
Phagocytosis | 1 | 1986 | 1526 | 0.000 |
Why?
|
Syndrome | 1 | 1985 | 3268 | 0.000 |
Why?
|
Adolescent | 1 | 1987 | 88234 | 0.000 |
Why?
|
Transplantation, Homologous | 1 | 1987 | 4804 | 0.000 |
Why?
|
Drug Combinations | 1 | 1983 | 2048 | 0.000 |
Why?
|
Brain Diseases | 1 | 1985 | 1545 | 0.000 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1983 | 1779 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1986 | 2768 | 0.000 |
Why?
|
Acute Disease | 1 | 1985 | 7237 | 0.000 |
Why?
|
Massachusetts | 1 | 1986 | 8833 | 0.000 |
Why?
|
Hospitals | 1 | 1986 | 3877 | 0.000 |
Why?
|
Transcription Factors | 1 | 1991 | 12116 | 0.000 |
Why?
|
Chronic Disease | 1 | 1985 | 9311 | 0.000 |
Why?
|
Rats | 1 | 1986 | 23717 | 0.000 |
Why?
|
Cohort Studies | 1 | 1989 | 41457 | 0.000 |
Why?
|
Hospitalization | 1 | 1986 | 10704 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 1986 | 26049 | 0.000 |
Why?
|
Retrospective Studies | 1 | 1987 | 80566 | 0.000 |
Why?
|